about
Anti-Fas mAb-induced apoptosis and cytolysis of airway tissue eosinophils aggravates rather than resolves established inflammation.Up-regulation of Toll-like receptors 2, 3 and 4 in allergic rhinitis.Occurrence of apoptosis, secondary necrosis, and cytolysis in eosinophilic nasal polyps.Direct evidence of secondary necrosis of neutrophils during intense lung inflammation.Resolution of airway disease: removal of inflammatory cells through apoptosis, egression or both?The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids.Induction of vascular remodeling in the lung by chronic house dust mite exposure.A module-based analytical strategy to identify novel disease-associated genes shows an inhibitory role for interleukin 7 Receptor in allergic inflammation.MicroRNA expression profiling in mild asthmatic human airways and effect of corticosteroid therapy.Human urinary bladder smooth muscle is dependent on membrane cholesterol for cholinergic activation.Altered fibroblast proteoglycan production in COPD.Effects of a dual CCR3 and H1-antagonist on symptoms and eosinophilic inflammation in allergic rhinitisIn vivo paradigms of diseased airway mucosa: selected aspects of innate immunity and eosinophils.Early phase resolution of mucosal eosinophilic inflammation in allergic rhinitisControlled and uncontrolled asthma display distinct alveolar tissue matrix compositions.New aspects of degranulation and fates of airway mucosal eosinophils.Degranulation patterns of eosinophil granulocytes as determinants of eosinophil driven disease.Indigenous enteric eosinophils control DCs to initiate a primary Th2 immune response in vivoPeptidylarginine deiminases present in the airways during tobacco smoking and inflammation can citrullinate the host defense peptide LL-37, resulting in altered activities.Enhanced ROCK1 dependent contractility in fibroblast from chronic obstructive pulmonary disease patients.Late onset vascular dysfunction in the R6/1 model of Huntington's disease.Elevated pulmonary arterial pressure and altered expression of Ddah1 and Arg1 in mice lacking cavin-1/PTRF.Elevated exhaled nitric oxide in allergen-provoked asthma is associated with airway epithelial iNOS.Midkine is expressed and differentially processed during chronic obstructive pulmonary disease exacerbations and ventilator-associated pneumonia associated with Staphylococcus aureus infection.Neutrophil cannibalism--a back up when the macrophage clearance system is insufficient.Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis.Airway epithelial repair: breathtakingly quick and multipotentially pathogenic.A major population of mucosal memory CD4+ T cells, coexpressing IL-18Rα and DR3, display innate lymphocyte functionalityAirway microvascular extravasation and luminal entry of plasma.Expression of Toll-like receptor 9 in nose, peripheral blood and bone marrow during symptomatic allergic rhinitis.Osteopontin That Is Elevated in the Airways during COPD Impairs the Antibacterial Activity of Common Innate Antibiotics.Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours.IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways.Small airway epithelial-C/EBPβ is increased in patients with advanced COPD.Effects of intranasal TNFalpha on granulocyte recruitment and activity in healthy subjects and patients with allergic rhinitis.Remodeling of extra-bronchial lung vasculature following allergic airway inflammation.Pulmonary and pleural lymphatic endothelial cells from pediatric, but not adult, patients with Gorham-Stout disease and generalized lymphatic anomaly, show a high proliferation rate.Lung delivery studies using siRNA conjugated to TAT(48-60) and penetratin reveal peptide induced reduction in gene expression and induction of innate immunity.Increased number and altered phenotype of lymphatic vessels in peripheral lung compartments of patients with COPD.Fibrocytes are associated with vascular and parenchymal remodelling in patients with obliterative bronchiolitis
P50
Q24814265-CE04A97C-5EC7-4027-89A0-EAACAA640BD2Q24814712-E8E636F9-95DA-46C2-9866-AEA46AF52D27Q33204402-A4EDE875-CFE6-44BF-803F-A6B728BBA37CQ33235178-98AC7D8E-C7F7-4DDE-9E5C-47DDE1AE5077Q33252232-5B0F365E-74B7-443C-A9DF-B317D5688AD6Q33294346-36D2DC8A-BD5C-4981-BEAA-2F3DCDD8D122Q33322072-888A28BC-8F2C-44BC-A401-0F7673730C3CQ33409104-FE9EC644-1BEF-47C2-9A64-6B8501F29134Q33466773-0A25A8CF-8D22-46F0-9D92-1067AEA7BBECQ33533499-8757101A-324D-42D4-8953-C17C52193A1BQ33575567-50BD1CF5-23D3-4B7B-A1A6-8EF07CE54415Q33707735-2FFFA386-E316-4C84-89FA-DCB3A28A300AQ33775596-06C120D4-A262-4367-B25B-5D0A587BFB64Q33866414-4E4DFA30-D6CF-4E19-A588-860154706AB4Q33874172-B0EA7CF5-F6BE-4389-ABFF-651CA22936EBQ33942417-29B384A2-1E23-45AD-A35D-1BD4B03D3A85Q33943245-17C2D475-EFCE-4CBA-BDF4-E48D2A2011A2Q33964249-89E12FA7-5E46-43AD-B58B-9F7C5C25B58AQ34035658-DFD695E7-F52E-4F08-85A0-DC77AC03E2C2Q34389888-B27384DE-F729-4D8C-89CD-B9410CEDCE84Q34464016-212EA391-A7A5-4F9A-BA16-7B404FA95D61Q35058706-5821982C-E91B-425D-A256-3D3D63BD90ACQ35108583-394092DE-A879-47FD-8A70-FDACC153D5E6Q35130888-87FBDFDA-6F93-455D-B670-032FD2CD5815Q35250844-300AB7F5-4134-4271-AAE1-C53166C246B6Q35531817-4B289E2B-C4A7-4555-A988-75217303CB4BQ35563219-3ECFC2FA-4928-4F38-B534-511DC52E142DQ35583278-2D46FD94-D66F-4D0C-B8E9-F9B20CA17AADQ35583611-A8DF9AE6-9E0F-4427-908E-5C88EA1E43C1Q35663366-9F907F4C-3F88-4183-880E-17186467519CQ35885852-3052C10C-9504-403C-9569-F2BF38270317Q35965396-136C6788-937D-45EE-BEE8-D62E11C31706Q36064607-213A5F5E-2BD4-42B7-9E85-8BBA58E94905Q36222700-2100C8C3-84B0-45AF-AE6F-61003FF860F8Q36477126-542411B3-1B68-4A10-A569-7C1530B143D4Q36478639-11E7BD02-408E-4961-86EA-46B6ECCE4AB4Q36911140-94A956FA-7F24-440A-A71F-DAF292A6A586Q37052581-299CE9C0-3302-498C-86AB-A2978EE1CEBDQ37056838-FDDDF7F9-2CD1-4A71-9F19-21726B37AECEQ37414229-432D532A-F249-4974-842E-398A6AF8DE23
P50
description
Zweeds onderzoeker
@nl
hulumtues
@sq
researcher
@en
taighdeoir
@ga
հետազոտող
@hy
name
Jonas S Erjefält
@ast
Jonas S Erjefält
@en
Jonas S Erjefält
@es
Jonas S Erjefält
@ga
Jonas S Erjefält
@nl
Jonas S Erjefält
@sl
Jonas S Erjefält
@sq
type
label
Jonas S Erjefält
@ast
Jonas S Erjefält
@en
Jonas S Erjefält
@es
Jonas S Erjefält
@ga
Jonas S Erjefält
@nl
Jonas S Erjefält
@sl
Jonas S Erjefält
@sq
prefLabel
Jonas S Erjefält
@ast
Jonas S Erjefält
@en
Jonas S Erjefält
@es
Jonas S Erjefält
@ga
Jonas S Erjefält
@nl
Jonas S Erjefält
@sl
Jonas S Erjefält
@sq
P106
P108
P21
P27
P31
P496
0000-0002-6716-3010